-
Expanding Registry for Research
https://braincanada.ca/about/news-updates/expanding-registry-for-researchPHOTO: Brain Canada President & CEO Viviane Poupon and Canadian Neuromuscular Disease Registry Executive Director Victoria Hodgkinson in Calgary, Alberta on May 27, 2025. Brain Canada is investing in transformative research platforms across the country to accelerate neuroscience discovery and...
-
Exploitation of a new pharmacological target for the development and validation of new anti-inflammatory drugs
https://braincanada.ca/funded-grants/exploitation-of-a-new-pharmacological-target-for-the-development-and-validation-of-new-anti-inflammatory-drugsNeuroinflammation has been implicated in a diverse array of degenerative conditions, ranging from Multiple Sclerosis to Alzheimer’s disease. Project Overview Neuroinflammation has been implicated in a diverse array of degenerative conditions, ranging from Multiple Sclerosis to Alzheimer’s ...
-
Exploring a cellular mystery
https://braincanada.ca/about/news-updates/exploring-a-cellular-mysteryDr. Maria Vera Ugalde loves fundamental biology. As a biochemist at McGill University, she spends her days using advanced microscopy techniques to see into the intricate workings of our cells. Will this new way of looking at certain protective proteins better explain their role in ALS? Award:...
-
Exploring a therapeutic approach to promote neuronal function for ALS
https://braincanada.ca/funded-grants/exploring-a-therapeutic-approach-to-promote-neuronal-function-for-alsAmyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating neurodegenerative diseases which have overlap in pathological features and the genetic basis. Project Overview Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating...
-
Exploring New Therapeutic Approaches for Medulloblastoma
https://braincanada.ca/funded-grants/exploring-new-therapeutic-approaches-for-medulloblastomaMedulloblastoma (MB) is a brain cancer that affects children. Medulloblastoma (MB) is a brain cancer that affects children. Current treatment for MB leaves patients with debilitating brain issues. We found that aggressive MB have low activity of a process called nonsense mediated decay (NMD)....
-
Exploring the complexities of dementia risk in females: role of pregnancy history and the gut-brain axis
https://braincanada.ca/funded-grants/exploring-the-complexities-of-dementia-risk-in-females-role-of-pregnancy-history-and-the-gut-brain-axisWomen have a higher lifetime risk of Alzheimer’s disease (AD), possibly due to female-specific factors like menopause and pregnancy history. Project Overview Women have a higher lifetime risk of Alzheimer’s disease (AD), possibly due to female-specific factors like menopause and pregnancy history....
-
Exploring the involvement of TDP-43 SUMOylation in ALS pathogenesis
https://braincanada.ca/funded-grants/exploring-the-involvement-of-tdp-43-sumoylation-in-als-pathogenesisTDP-43 is an essential DNA/RNA binding protein at the epicenter of Amyotrophic Lateral Sclerosis (ALS). Project Overview TDP-43 is an essential DNA/RNA binding protein at the epicenter of Amyotrophic Lateral Sclerosis (ALS). Nearly all cases of ALS present with TDP-43 pathology involving nuclear to...
-
Exploring the mind-gut connection to see how stress can promote inflammation and lead to depression.
https://braincanada.ca/about/news-updates/exploring-the-mind-gut-connection-to-see-how-stress-can-promote-inflammation-and-lead-to-depression -
Exploring the Potential of Reinforcement Learning in Pediatric Speech and Language Therapy
https://braincanada.ca/funded-grants/exploring-the-potential-of-reinforcement-learning-in-pediatric-speech-and-language-therapyWe are working on an innovative project to improve speech therapy for children who have trouble speaking or understanding language. Project Overview We are working on an innovative project to improve speech therapy for children who have trouble speaking or understanding language. We’re using a type...
-
Exploring the relationship between synaptic density marker SV2A PET imaging and acute neuroplastic potential with interleaved TMS-fMRI in treatment resistant depression
https://braincanada.ca/funded-grants/exploring-the-relationship-between-synaptic-density-marker-sv2a-pet-imaging-and-acute-neuroplastic-potential-with-interleaved-tms-fmri-in-treatment-resistant-depressionDepression is a common mental health condition that affects millions of Canadians. Project Overview Depression is a common mental health condition that affects millions of Canadians. While there are treatment options available, some patients do not respond to conventional antidepressants and...